Goldman Sachs
AONCW

Goldman Sachs’s American Oncology Network, Inc. Warrant AONCW Stock Holding History

Goldman Sachs’s Portfolio AONCW Stock Details AONCW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-210,455
Closed -$6.31K – 6203
2024
Q2 		$6.31K Hold
210,455
– – ﹤0.01% 5565
2024
Q1 		$71.6K Hold
210,455
– – ﹤0.01% 5288
2023
Q4 		$42.1K Hold
210,455
– – ﹤0.01% 5398
2023
Q3 		$34.7K Buy
210,455
+19,495
+10% +$4.51K ﹤0.01% 5312
2023
Q2 		$25.7K Hold
190,960
– – ﹤0.01% 5526
2023
Q1 		$9.55K Hold
190,960
– – ﹤0.01% 5745
2022
Q4 		$11.5K Hold
190,960
– – ﹤0.01% 5743
2022
Q3 		$13K Hold
190,960
– – ﹤0.01% 6005
2022
Q2 		$52K Hold
190,960
– – ﹤0.01% 6019
2022
Q1 		$76K Hold
190,960
– – ﹤0.01% 6182
2021
Q4 		$126K Hold
190,960
– – ﹤0.01% 6070
2021
Q3 		$131K Hold
190,960
– – ﹤0.01% 5861
2021
Q2 		$178K Buy
+190,960
New +$152K ﹤0.01% 5779

Goldman Sachs's AONCW Position: Q3 2024 in Review

Goldman Sachs sold out of American Oncology Network, Inc. Warrant (AONCW) in Q3 2024, closing a stake of 210,455 shares — an estimated $6.31K sold.

Goldman Sachs first reported a position in AONCW in Q2 2021 and held it in 13 quarters. The position peaked at $178K in Q2 2021. 0 funds tracked by Wall St. Rank hold AONCW as of Q3 2024.

  • Goldman Sachs reported no remaining American Oncology Network, Inc. Warrant position as of Q3 2024 after selling out during the quarter.
  • Goldman Sachs sold 210,455 American Oncology Network, Inc. Warrant shares in Q3 2024, an estimated $6.31K.
  • Goldman Sachs first reported a position in American Oncology Network, Inc. Warrant in Q2 2021 and held it in 13 quarters.
  • Goldman Sachs's American Oncology Network, Inc. Warrant position peaked at $178K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held American Oncology Network, Inc. Warrant as of Q3 2024.

Based on Goldman Sachs's 13F filing for Q3 2024, filed 14 Nov 2024.